Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LANXESS AG is a Germany-based company engaged in the chemicals sector. It specializes in the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Its business activities are divided into four segments: Specialty Additives, responsible for manufacture of additives for the rubber and paint industries, among others; Advanced Intermediates, focused on the development of intermediates for the agricultural, plastics, chemicals, consumer goods, construction, tire and automotive industries, among others; Performance Chemicals, which offers material protection products, inorganic pigments, finishing agents for the leather industry and resins for water treatment, among others, and Engineering Materials, which produces technical plastics, glass fibers, fiber composites and elastomers on a urethane basis for application in the automotive, electronics and electrical engineering industries. It operates around 60 production sites worldwide.

  • Revenue in EUR (TTM)6.32bn
  • Net income in EUR-689.00m
  • Incorporated2004
  • Employees12.39k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AlzChem Group AG557.99m50.10m606.51m1.69k12.133.157.951.094.914.9154.7018.921.231.718.03330,365.3011.067.0114.529.0464.3357.929.015.791.3912.280.0037.29-0.2903--15.20------
Lanxess AG6.32bn-689.00m2.01bn12.39k--0.45886.550.3174-7.98-10.0273.1850.630.63113.579.25491,789.30-6.871.25-8.021.5619.3923.80-10.891.801.17-2.470.407758.76-16.99-0.3245-557.61---8.09-35.56
K+S AG3.70bn25.50m2.02bn11.48k80.080.32333.850.54550.14080.142520.6334.870.39674.735.49323,403.500.28184.200.31065.017.7723.470.710411.212.24--0.075618.81-31.78-0.8384-86.0837.89-1.3022.87
Wacker Chemie AG5.86bn124.40m3.70bn16.56k28.310.78886.340.63072.502.50118.0389.880.66123.206.45357,968.001.635.162.026.2914.7221.652.466.601.51--0.280466.04-22.015.16-74.934.979.373.71
Evonik Industries AG15.16bn228.00m8.20bn33.58k36.630.90926.330.54070.48030.480332.0219.350.75144.228.64453,859.801.212.011.542.4225.2525.471.612.900.73719.950.3168130.72-17.422.85-186.27---3.510.3454
Brenntag SE16.19bn544.50m8.76bn17.70k16.502.009.890.54083.673.67109.0730.281.498.206.72914,269.605.106.407.309.0224.6623.033.414.021.0410.120.434837.40-13.456.03-19.389.1812.4711.84
Data as of Nov 25 2024. Currency figures normalised to Lanxess AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.